Sheila Moran

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Regis Technologies, Inc. is a private company that offers high-quality GC derivatization reagents for gas chromatography separations. Regis Technologies is based in Morton Grove, IL and offers a range of services including solid-state chemistry, impurity services, custom API manufacturing, and more. The company provides process and analytical development of small molecule APIs for pharma companies, as well as chromatography consumables. The company partners with pharma and biotech companies to expedite small molecule drug candidates to market with CGMP manufacturing services and products. The company also provides technical and customer support, safety data sheets, certificates of analysis, and video/literature libraries. The company has a CGMP facility with a range of equipment and capabilities to manufacture lead molecules, and they offer chromatography products including chiral and achiral columns for SFC, RPLC, and specialty reagents. Quality assurance ensures the CGMP compliance of products, tracking all CGMP production from raw material receipt to final product release.

Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.